Financiere des Professionnels - Fonds d,investissement »

Bristol Myers Squibb shares owned by Financiere des Professionnels - Fonds d,investissement

Quarter-by-quarter ownership of Bristol Myers Squibb (BMY) shares owned by Financiere des Professionnels - Fonds d,investissement from 13F filings

Historical chart of Financiere des Professionnels - Fonds d,investissement investment in Bristol Myers Squibb

Tip: Access up to 7 years of quarterly data

All positions including Bristol Myers Squibb held by Financiere des Professionnels - Fonds d,investissement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bristol Myers Squibb by Financiere des Professionnels - Fonds d,investissement

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.9M 65k 45.10
2024-12-31 $232k 4.1k 56.56
2024-09-30 $212k 4.1k 51.74

More positions owned by Financiere des Professionnels - Fonds d,investissement

Ishares Core Msci Emkt (IEMG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr 0-5yr Invt Gr Cp (SLQD)
Charles Schwab Corporation (SCHW)
Becton, Dickinson and (BDX)
Ishares Tr Msci Emg Mkt Etf (EEM)

View all positions for Financiere des Professionnels - Fonds d,investissement

Top funds holding Bristol Myers Squibb

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Charles Schwab Investment Management
Geode Capital Management
Ameriprise Financial
Capital Research and Management Company - Division 3
Morgan Stanley
Northern Trust
PRIMECAP Management Company
Ubs Global Asset Management Americas
Independent Franchise Partners
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding Bristol Myers Squibb